Chronic pancreatitis is characterized by fibroinflammatory changes to the pancreatic tissue. It may develop in association with alcohol abuse, smoking, gene mutations, autoimmune syndromes, metabolic disturbances, environmental conditions and anatomical abnormalities. [1] [2] [3] Chronic pancreatitis is a rare disease that affects from 7 to 10 persons/ 100 000 per year. 4 The largest numbers of patients are found in industrialized countries and approximately 80% of them are alcoholics. Alcoholic pancreatitis and most of the other etiological forms present in adulthood. Exceptions are hereditary pancreatitis, which may already occur in childhood, and tropical pancreatitis, which often affects adolescents. 5 The pathology of chronic pancreatitis was formerly considered to be uniform, but currently it is more and more seen as varying according to the etiology of the disease. The rather vague term chronic sclerosing pancreatitis should and can be replaced by etiologically derived terms, such as alcoholic chronic pancreatitis, hereditary pancreatitis, autoimmune pancreatitis, [6] [7] [8] [9] [10] [11] paraduodenal pancreatitis ('groove pancreatitis', 'cystic dystrophy of heterotopic pancreas') [12] [13] [14] and obstructive chronic pancreatitis. Some morphological features, such as the composition of the inflammatory infiltrate and the fibrosis pattern, may be a clue to a certain etiology. 15 For instance, the development of fibrosis, whether it is more inter (peri) lobular or intralobular, depends very much on the site of the initial injury in the pancreas and this is strongly related to the acting etiological factor. Apart from these more general mechanisms, chronic pancreatitis is very much an individualized disease that, although driven by the same etiology, may progress rapidly in one patient while developing slowly and being clinically insignificant in another patient.
For the pathogenesis it is important to note that alcoholic chronic pancreatitis, hereditary pancreatitis and duodenal wall pancreatitis evolve from recurrent acute pancreatitis. [15] [16] [17] Further, a diagnosis of chronic pancreatitis must take into account that the pancreas of patients over 60 may show fibrosis that is not associated with the clinical symptoms of chronic pancreatitis but seems to be the result of hyperplastic changes in the epithelium of secondary ducts. 15 
Classification
Since 1963 several classifications of chronic pancreatitis have been introduced. 18, 19 These classifications were mainly concerned with the distinction between acute and chronic pancreatitis. Moreover, they focused primarily on alcohol-induced chronic pancreatitis and only marginally considered the nonalcoholic types. Finally, none of the classifications correlated the etiology with morphological, functional and clinical features. Hence, there is still a need for a classification that includes all currently available criteria for the characterization of the various types of chronic pancreatitis. Table 1 presents a classification proposal based on the etiology of the disease.
Alcoholic chronic pancreatitis

Clinical Features
The patients are usually young to middle-aged men (25-50 years) , who develop the disease after approximately 10 years of alcohol abuse. The younger the patients are when they begin their abuse, the shorter the time required for chronic pancreatitis to develop seems to be. However, of the total number of heavy drinkers, only 10% suffer from chronic pancreatitis. At the early stage of alcoholic chronic pancreatitis, patients experience relapsing episodes of acute pancreatitis, particularly with severe recurrent pain. In its advanced stage, alcoholic chronic pancreatitis is characterized by pain, steatorrhea and diabetes. In addition, patients with this disease have an increased risk of developing a pancreatic carcinoma later in life, particularly if they have a hereditary form of chronic pancreatitis that starts very early in life. 4, 20 
Pathology
In the early stages of alcoholic chronic pancreatitis, the gland shows unevenly distributed fibrosis. The involved parts of the gland appear indurated and may be enlarged, showing coarse lobulation and/or nodular scarring on the cut surface. Only the ducts that are embedded in fibrotic tissue show irregularities and occasionally may contain calculi (calcified protein plugs) (Figure 1 ). In 30-50% of the cases there may be pseudocysts, which are usually extrapancreatic 16, [21] [22] [23] and commonly occur in the region around the body and tail of the pancreas. In addition, there are foci of recent necrosis in the vicinity of scars 24 and pseudocysts. In advanced chronic pancreatitis, the pancreas has a firm consistency and usually shows an irregular contour without the normal lobulation. 17, 25 The fibrosis may diffusely affect the entire gland, but occasionally it is still unevenly distributed, leaving the lobular pattern of the organ preserved in some areas (Figure 2 ). The severity of the duct changes depends on the extent of the surrounding fibrosis. Thus, the main duct may be only focally obstructed and/or dilated or diffusely involved with irregular dilatation and distortion. Usually (80%) it contains calculi. The calculi, which consist of calcium carbonate, vary in size from less than 1 mm to more than 1 cm in diameter. They may be impacted in the ducts and therefore difficult to remove. In some cases, they may disappear during the course of the disease. 23, 26 Fibrosis in the pancreas head may cause a tapering stenosis of the common bile duct (Figure 3 ). Thick-walled pseudocysts, usually attached to the pancreas, are present in one quarter to one half of the cases. 21 They vary in size (3-10 cm in diameter) and are filled with necrotic material and/or turbid fluid rich in enzymes. The pseudocysts may be connected with the duct system. Occasionally, they may erode the major portal veins causing thrombosis, bleeding and, rarely, disseminated fat necrosis with subcutaneous nodular panniculitis, polyarthritis and necrotic bone marrow lesions. 23 Histological examination of the early stages of the disease reveals interlobular (perilobular) cell-rich fibrosis 16, 27, 28 (Table 2 , Figure 4 ). The involved intralobular ducts are distorted and may contain eosinophilic secretions, the so-called protein plugs. In addition, the epithelium may display metaplastic or hyperplastic changes. Moderate numbers of lymphocytes, plasma cells and macrophages are present, either in local accumulations or scattered diffusely throughout the fibrous tissue. In the perilobular tissue, there may be foci of resolving fat necrosis ( Figure 5 ) with large numbers of vacuolated macrophages (foam cells) in the immediate vicinity and cell-rich fibrosis in the surrounding area. The necrotic foci are often in the vicinity of large pseudocysts, which lie outside the pancreatic parenchyma.
In advanced chronic pancreatitis, fibrosis affects most of the parenchyma, but still to varying degrees. 16, 27, 29 While in some areas there is only perilobular fibrosis (Figure 6a ), others show diffuse intralobular fibrosis with sparse lymphocytic infiltrates. Perilobular fibrosis causes duct distortions and dilatations with occasional formation of a retention cyst. The lumens of these interlobular ducts are often filled with protein plugs and calculi (Figure 6b ). The duct epithelium is either atrophic or completely replaced by polymorphocellular inflammatory tissue. In areas with intralobular fibrosis, the elements that remain are islets, thick-walled blood vessels, prominent nerves and remnants of acinar cells, which may be atrophic, undergo apoptosis, or form the so-called tubular complexes. 30 The nerves have been found to be damaged by the inflammatory process. 31 The islets may form large ('adenomatoid') aggregates (Figure 7 ), which are sometimes in close contact with ductules that show islet cell neoformation. 32 The number of beta cells in these islets was found to be slightly reduced. 32 Immunohistological studies revealed that the duct epithelium commonly expresses HLA-DR and cytokines such as transforming growth factors alpha and beta (TGFa, TGFb1) and fibroblast growth factor (FGF) [33] [34] [35] [36] [37] [38] TGFb1 and platelet derived growth factor (PDGF) were also found in fibroblasts, macrophages and/or platelets. 28, 39, 40 Myofibroblasts, which were recently named pancreatic stellate cells, are identified by their positivity for smooth muscle actin and desmin 15 ( Figure 8 ). 28, [41] [42] [43] The lymphocytic infiltrate consists largely of T lymphocytes. 33, 34 The remaining acinar cells stain brightly for pancreatic enzymes and pancreatic stone protein. 44, 45 The nerves that appear enlarged express particularly calcitonin-gene related peptide and substance P. 46 Both the endothelial cells and endocrine beta and alpha cells show strong endothelin-1 expression in chronic pancreatitis. 47 
Symptoms, Function and Complications
Persistent stenosis of the bile duct develops in approximately 10% of the cases, 48 duodenal stenosis in about 3%. 29 These complications are either due to intensive scarring or to the development of a pseudocyst in the head of the pancreas.
Pseudocysts are found in 30-50% of patients with chronic pancreatitis. 16, 21 They are usually thickwalled, the wall consists of granulation and fibrous tissue and lacks an epithelial lining. 21 Identical features are observed in pseudocysts associated with acute pancreatitis. Pseudocysts are usually connected with the duct system and therefore rich in pancreatic enzymes. They may expand and exert pressure on the surrounding organs. Further complications are fistulas into the pleura, leakage of pancreatic juice into the peritoneal cavity (pancreatic ascites), or hemorrhages from eroded vessels into the cysts and the pancreatic duct system. Some pancreatic duct stents used for the treatment of chronic pancreatitis have been found to cause changes in the duct system that may aggravate the chronic pancreatitis they are treating. 49, 50 With increasing fibrosis of the pancreas, the patients develop exocrine and endocrine insufficiency. 16 Exocrine insufficiency results in maldigestion, which usually becomes obvious after 80-90% of the parenchyma has been replaced by fibrosis. The incidence of diabetes increases with the duration and severity of chronic pancreatitis. 16 The question whether chronic pancreatitis involves an increased risk for the development of pancreatic ductal carcinoma has been a controversial issue for years. It now appears that patients with chronic pancreatitis, particularly if they have the hereditary form, 51 have a higher risk of developing pancreatic carcinoma than the normal population. 20, 52 It is interesting that K-ras mutations, which are very common in ductal adenocarcinoma, may also occur in the hyperplastic duct epithelium of the pancreas in patients with chronic pancreatitis, particularly with a duration of more than 3 years. 53 
Pathogenesis
In all westernized countries, alcohol is the most common cause of chronic pancreatitis. 54, 55 In addition, smoking seems to be an independent etiological factor. 56 The reason why only 10% of alcoholics develop chronic pancreatitis is unclear. 57 Presumably, there is an additional (genetic?) factor in the development of alcoholic chronic pancreatitis that makes certain patients more susceptible to the disease than others. Recently, mutations of the cystic fibrosis transmembrane regulator gene (CFTR) have been implicated in the pathogenesis of chronic pancreatitis and it has been suggested that the functional consequences of these mutations (ie impaired flow of secretion) could predispose their bearer to the development of chronic pancreatitis. 58 Whether the alcoholic who remains free of chronic pancreatitis may develop some particular kind of diffuse fibrosis of the pancreas 59 distinct from that which can be seen in elderly patients without any known risk factors for chronic pancreatitis has yet to be established.
Several theories have been put forth to explain the pathogenesis of alcoholic chronic pancreatitis. The most popular hypothesis is that of Sarles et al, 60 who suggested that chronic ethanol consumption increases the protein concentration in the pancreatic juice with subsequent precipitation of plug-forming secretions in the ducts, which later calcify. More recently, Sarles' group 61-63 identified a protein in pancreatic juice that prevented CaCO 3 precipitation and was therefore called lithostatin (formerly pancreatic stone protein). It is thought that abnormal secretion of lithostatin due to either an acquired or an inherited defect in its biosynthesis contributes to the calcification of protein plugs in the pancreatic ducts. The formation of stones leads in turn to duct obstruction and ulceration of duct epithelium, two mechanisms that cause acinar atrophy and fibrosis upstream of the obstruction as well as periductular inflammation. Although this hypothesis is attractive, it has been criticized for several reasons. First, the findings concerning altered lithostatin biosynthesis and function in chronic pancreatitis have not been universally confirmed. [64] [65] [66] Second, the hypothesis only recognizes chronic pancreatitis as an alcohol-induced disease and neglects the fact that acute pancreatitis may also be caused by alcohol. [67] [68] [69] [70] Third, alcoholic acute and chronic pancreatitis have many features in common, such as clinical symptoms and the presence of pseudocysts. Fourth, in alcoholic acute pancreatitis, no pre-existent changes due to chronic pancreatitis have been found, whereas the pancreas of patients with chronic pancreatitis may show signs of acute pancreatitis, such as autodigestive tissue necrosis. 21, 25 Fifth, in its early stages chronic pancreatitis lacks calcifications. 16 In recent years, the plug hypothesis has been challenged by the necrosis-fibrosis sequence concept. 24, 71 This theory postulates that alcoholic chronic pancreatitis is initiated by relapsing severe acute pancreatitis. 16, 72 The resorption of large areas of fat necrosis and hemorrhagic necrosis, which are the main events in severe acute (necrotizing) pancreatitis, 17 induce fibrosis, possibly through the action of growth factors such as TGFa and TGFb 37 ( Figure 9 ). 35 The fibrosis develops primarily in the perilobular space, where fat necrosis and most of the hemorrhagic necrosis occur. 15, 17 Perilobular fibrosis in turn affects the structure of the interlobular ducts, gradually creating duct dilatations and strictures 73 ( Figure 10 ). In these altered ducts, the flow of secretions is most likely impaired, a situation that may trigger the spontaneous precipitation of proteins with subsequent calcification. In addition, the impaired and eventually interrupted flow of pancreatic secretions leads to fibrotic replacement of the acinar cells upstream from the occluded duct and finally results in intralobular fibrosis.
Although the necrosis-fibrosis sequence nicely explains the perilobular fibrosis pattern, the patchy distribution of fibrosis and the late occurrence of calcifications in the pancreas of patients with alcoholic chronic pancreatitis, certain questions still need to be answered. First, it is difficult to reconcile the fact that the necrosis-fibrosis sequence also holds true for the primary painless chronic pancreatitis that may be observed in 5-10% of alcoholics [74] [75] [76] Second, biliary acute pancreatitis, which may occasionally be as severe as alcoholic pancreatitis, virtually never progresses to chronic pancreatitis.
A third hypothesis, called the 'toxic-metabolic hypothesis' was put forth by Bordalo et al 77 and Noronha et al 78 This hypothesis postulates that chronic alcohol consumption induces progressive acinar lipid deposition with acinar atrophy and intrapancreatic fibrosis by exerting direct toxic and metabolic effects on the acinar cells. Because the described pancreatic changes, particularly the fatty degeneration of acinar cells, have not been confirmed by others, the significance of this concept for the pathogenesis of alcoholic chronic pancreatitis seems to be minor.
The fourth hypothesis, the 'oxidative stress hypothesis', 79 postulates that oxidative stress in pancreatic acinar cells induced by excess free radicals causes a blockade of the intracellular pathway, fusion of lysosomal and zymogenic compartments, and membrane lipid oxidation. These events then lead to an inflammatory response. The hypothesis focuses on possible functional disturbances underlying acinar failure, but fails to explain the particular fibro-inflammatory process that characterizes chronic pancreatitis.
Hereditary pancreatitis
Clinical Findings
Hereditary pancreatitis usually starts already in childhood or adolescence. Clinically, it resembles alcoholic pancreatitis. It is very rare, compared with alcoholic chronic pancreatitis, and accounts for no more than 1-2% of all patients. 5 
Pathogenesis
It has recently been shown that the genetic alterations in hereditary chronic pancreatitis involve the cationic trypsinogen gene (PRSS1) or the serine protease inhibitor Kazal type 1 (SPINK1) gene. [80] [81] [82] The third gene with mutations associated with chronic pancreatitis is the cystic fibrosis gene, CFTR. Mutations in the first two genes, PRSS1 and SPINK1, seem to trigger the autoactivation of trypsinogen in the pancreas, which in turn results in the early inappropriate activation of the other pancreatic enzymes with subsequent autodigestive necrosis and inflammation. The most important trypsinogen gene mutations, R122H and N21I, are gain of function mutations and have a disease penetrance of 80%.
58 SPINK1 mutations are loss of function mutations and may result in elevated trypsin levels within the pancreas. So far the role of the CFTR mutations in the pathogenesis of chronic pancreatitis is unclear.
Pathology
We do not yet know where in the pancreas the premature activation of trypsin takes place. It may occur either already in the acinar cells or only in the duct system. We studied pancreatic resection specimens from six patients with hereditary chronic pancreatitis (unpublished observation) and found advanced chronic pancreatitis with massively dilated ducts containing protein plugs and calculi ( Figure 11) . The fibrosis showed a periductal and interlobular pattern (Table 2 ). In one case, there was ductal necrosis in some of the medium-sized interlobular ducts that destroyed the duct epithelium and led to an intense chronic inflammatory reaction in the periductal area ( Figure 12 ). This finding suggests that the autodigestive process in hereditary chronic pancreatitis may occur in the duct lumen, resulting initially in necrosis of the duct-lining cells and subsequently affecting the surrounding interstitial tissue. If we hypothesize that the relapsing autodigestive necrosis occurs particularly in the large ducts, it may gradually induce scarring of the surrounding interstitial tissue with subsequent dilatation of the involved duct segments. In addition, there may also be autodigestive necrotic events in the interlobular areas next to ducts that initiate and promote interlobular fibrosis. Large areas of necrosis may be transformed into a Figure 10 Natural history of alcoholic pancreatitis. Mild acute pancreatitis is characterized by spotty peripancreatic fat necrosis, which is resolved without inducing significant fibrosis. Severe acute pancreatitis with large confluent areas of peripancreatic necrosis, but little intrapancreatic involvement, leads to an extrapancreatic pseudocyst. Relapse of severe acute pancreatitis with extensive extra-and intrapancreatic foci of necrosis induces perilobular fibrosis and duct distortions. In addition, there may be extrapancreatic pseudocysts. Early stage chronic pancreatitis evolve into end-stage chronic pancreatitis with severe duct changes, diffuse but still patchy fibrosis and calculi (adapted from Klö ppel 73 ).
Chronic pancreatitis, pseudotumors and other tumor-like lesions G Klöppel pseudocyst. 83 The calculi found in the dilated ducts are probably a result of the obstructed flow of pancreatic secretions, which promotes the precipitation of calcium from the pancreatic juice.
Autoimmune pancreatitis
In recent years, autoimmune pancreatitis has been established as a special type of chronic pancreatitis. The first reports describing such pancreatitis date back more than 50 years. Ball et al 84 described patients with pancreatitis in conjunction with ulcerative colitis. In 1961, Sarles et al 85 reported a case of sclerosing pancreatitis with hypergammaglobulinemia. The term autoimmune pancreatitis was coined in the 1990s. 86 Meanwhile, a number of reports on individual cases or small series of cases using other terms, such as lymphoplasmacytic sclerosing pancreatitis with cholangitis, 7 nonalcoholic duct destructive chronic pancreatitis 6 and chronic sclerosing pancreatitis, have been published. 87 
Clinical Findings
Most patients suffering from autoimmune pancreatitis are 40-60 years old (mean: 56). 6, 10, 11, 88 It appears that the patients who have a more pronounced neutrophilic inflammatory cell infiltrate ('granulocytic epithelial lesions') 11 are usually in their mid40s. The gender ratio also varies with the histologic pattern; the younger group with neutrophilic inflammation contains equal numbers of men and women, whereas the older group lacking neutrophils is predominantly male (ratio 3:1).
Clinical symptoms include abdominal pain, anorexia and jaundice. Jaundice is caused by direct involvement of the bile duct by the fibroinflammatory process and occurs in about 75-80% of the patients. In approximately 20% of the patients, there are associated diseases that are thought to be of autoimmune origin: Sjö gren's syndrome, idiopathic retroperitoneal fibrosis, lymphocytic thyroiditis and ulcerative colitis. Some of these conditions appear to be more common in one of the two clinical subgroups of patients. Sjö gren's syndrome is more often reported in older male patients without neutrophilic inflammation, whereas chronic inflammatory bowel disease often occurs in the younger patients who have neutrophilic inflammatory infiltrates in the pancreas. 9, 11 Patients with autoimmune pancreatitis may have autoantibodies such as antinuclear, antilactoferrin, antismooth muscle and anticarbonic anhydrase II antibodies. 89, 90 More recently it has been observed that IgG4 levels are commonly elevated in patients with autoimmune pancreatitis. 91 Elevated IgG4 levels have been used to correctly classify patients with pancreatic masses. 92 Imaging of the pancreas by CT or MRI often discloses a diffusely or segmentally enlarged pancreas with obliteration or stenosis of the main pancreatic duct. Bile duct strictures also occur when the disease affects the head of the gland. Ultrasonography may reveal a diffusely swollen hypoechoic pancreas, which has been referred to as 'sausage-like.'
Pathology
Information about the pathology of autoimmune pancreatitis is available from case reports and several small series that were recently published. 6, 7, 9, 10, 87, 88, 93, 94 Our knowledge is based on a series of 63 cases that were accumulated in Germany, Belgium and Italy.
11
The gross appearance of autoimmune pancreatitis mimics pancreatic ductal carcinoma because the inflammatory process, like the carcinoma, commonly focuses on the head of the pancreas and leads to a gray to yellowish-white induration of the affected tissue with loss of its normal lobular structure ( Figure 13 ). The involved portions may be enlarged. These changes cause obstruction of the main pancreatic duct and usually also of the distal bile duct, including the papilla. 95 In a minority of cases, the inflammatory process is concentrated in the body or tail of the pancreas. Diffuse involvement of the pancreas may also be seen, but so far it is not known how frequently and to what extent the entire pancreas is affected in autoimmune pancreatitis. In contrast to other types of chronic pancreatitis, such as alcoholic chronic pancreatitis, hereditary pancreatitis and tropical pancreatitis, there are no pseudocysts. Calculi (ie intraductal calcifications) are usually absent, but if they occur, they seem to occur late in the course of the disease. 96 The hallmark of the histological changes in the pancreas in autoimmune pancreatitis is an intense inflammatory cell infiltration around medium-sized and large interlobular ducts. 6, 7, 9, 11 Smaller ducts may also be involved, but only in advanced cases. The inflammatory infiltrate consists mainly of lymphocytes and plasma cells (Figure 14 ), but also contains some macrophages and occasionally also neutrophilic and eosinophilic granulocytes. 97 Immunocytochemical typing of the lymphocytes reveals that most of them are CD8 and CD4 positive T lymphocytes with fewer B lymphocytes. The infiltrate completely encompasses the ducts and may narrow their lumen by infolding of the epithelium, often giving the lumen a star-like structure. In later stages, the duct wall is thickened by periductal fibrosis (Figure 15) .
In a number of cases, the chronic changes in the pancreas are overlain by 'granulocytic-epithelial' lesions of the ducts (Figure 16 ). This acute inflammatory component of autoimmune pancreatitis is characterized by focal detachment, disruption and destruction of the duct epithelium due to invading neutrophilic and occasionally also eosinophilic granulocytes, which may also cluster immediately beneath the duct epithelium. Sometimes the granulocytic infiltration extends into the small intralobular ducts and acini. Although these acute duct changes may be severe, total duct destruction leaving scars that replace the ducts seems to be a rare event.
The extension and severity of the chronic and acute changes in autoimmune pancreatitis vary from case to case and even from one area to another within a single pancreas. In some cases, the inflammatory process occupies only a relatively small part of the pancreas and alternates abruptly with areas in which only minimal inflammation is found or the pancreatic tissue is even normal. If the tissue is only slightly affected, the inflammation focuses almost entirely on the ducts, while in severely affected pancreases the inflammatory process involves the acinar parenchyma, in addition to the ducts, and leads to diffuse sclerosis 15 ( Figure 17 ) that may contain scattered B cell rich small lymphoid follicles. The acinar cells are then more or less replaced by inflammatory cells and fibrosis and the lobular architecture of the pancreas is almost lost. If the fibrotic changes occupy large areas that show myofibroblasts in a storiform arrangement, they may mimic the features of an inflammatory pseudotumor. 98, 99 In addition to the duct changes and the sclerotic process, there are vascular changes. Most frequent is vasculitis affecting the small veins ( Figure 18 ). Less common is obliterative arteritis.
If the inflammatory process affects the head of the gland (as in approximately 80% of the cases), it usually also involves the distal common bile duct, where it leads to a marked thickening of the bile duct wall due to a diffuse lymphoplasmacytic infiltration combined with fibrosis. In some cases, the inflammation also extends to the hepatic ducts of the liver hilus and the gall bladder wall. 100 The inflammatory process is usually well demarcated from the surrounding fatty tissue. The peripancreatic and peribiliary lymph nodes are enlarged and show follicular hyperplasia.
Biopsy
Recent studies suggest that biopsy can play a role in establishing the diagnosis of autoimmune pancreatitis. 11, 101 Thus, if a core biopsy specimen from the pancreas contains a duct with dense periductal lymphocytic inflammation, a vein with obliterative venulitis and/or a granulocytic epithelial lesion (Figure 19 ), the diagnosis can be suggested. Staining for IgG4 positive plasma cells and the demonstration of an increased number (420 cells per HPF) are 
Relationship to Inflammatory Pseudotumor and Primary Sclerosing Cholangitis
There are a number of reports on inflammatory (myofibroblastic) pseudotumors occurring in the head of the pancreas that involved the pancreatic duct as well as the distal common bile duct, 102 some associated with retroperitoneal fibrosis. [103] [104] [105] Judging from the descriptions and illustrations of these cases, these changes appear to be compatible with those seen in autoimmune pancreatitis. 99 As the clinical features of the reported inflammatory pseudotumors of the pancreas are also very similar, it is likely that these lesions may represent an advanced stage of autoimmune pancreatitis in which the fibrotic changes predominate and the disease focuses on a certain area. 11 The fact that inflammatory pseudotumors showing sclerosing cholangitis have been observed in the liver hilus 106 suggests that there is possibly an idiopathic pancreatobiliary inflammatory disease complex whose facets include autoimmune pancreatitis, extrahepatic sclerosing cholangitis and inflammatory pseudotumor of the pancreas and/or the common bile duct.
Inflammatory and sclerosing changes of the distal bile duct (which sometimes also involve the gallbladder) are very frequent and almost an integral part of autoimmune pancreatitis. Because of their similarity to extrahepatic primary sclerosing cholangitis, a relationship with this autoimmune liver disease has been discussed. However, the primary sclerosing cholangitis-like changes in the extrahepatic bile duct system that may be seen in autoimmune pancreatitis have so far never been found to be accompanied by intrahepatic primary sclerosing cholangitis. 100 Moreover, unlike typical primary sclerosing cholangitis, they appear to respond to steroid therapy. Therefore, it is likely that autoimmune pancreatitis, even if it involves the extrahepatic bile ducts, is a different disease and distinct from primary sclerosing cholangitis.
Pathogenesis
The inflammatory duct changes seen in autoimmune pancreatitis point to potential antigens within the duct epithelium that have become targets of an immmune process. Typing of the inflammatory duct-associated cells revealed CD4 þ and CD8 þ T cells to be the most common. 6, 90 Increased numbers of these T cells bearing HLA-DR were also found in the peripheral blood. 107 Subtyping of the CD4 þ cells according to their cytokine production profiles revealed a predominance of CD4 þ Th1 cells over Th2 cells in some cases, 107 similar to what has been reported in Sjö gren's disease 108 and primary sclerosing cholangitis. 109 HLA-DR antigens have also been detected on pancreatic duct cells. 6, 90 Finally, similar to other autoimmune diseases, autoimmune pancreatitis patients show a particular HLA haplotype, namely DRB1*0405-DQB1*0401. 110 Taken together these findings strongly suggest that autoimmune mechanisms may be involved in the pathogenesis of autoimmune pancreatitis. This concept is further supported by the common association of autoimmune pancreatitis with other autoimmune diseases, notably Sjögren's syndrome, 86 the frequent occurrence of various autoimmune antibodies such as antibodies against carboanhydrase II and nuclear antigens, 107 the elevated IgG4 serum levels and an increase in IgG4 positive plasma cells, 91, 111, 112 the oligoclonal pattern of T-cell receptor g gene rearrangements 98 and the responsiveness to steroid therapy. [113] [114] [115] [116] [117] What is unclear is how this immune process is triggered in the pancreas and why it is mostly focal and not diffuse, as might be expected from an autoimmune disease.
Differential Diagnosis
Clinically, radiographically and grossly autoimmune pancreatitis most commonly mimics pancreatic ductal carcinoma, because-like the carcinomait predominantly affects the pancreatic head and the bile duct. Histologically, however, it is not difficult to distinguish from ductal adenocarcinoma of the pancreas or other pancreatic malignancies. At the histological level, autoimmune pancreatitis has to be distinguished from alcoholic chronic pancreatitis (Table 2) . Autoimmune pancreatitis almost consistently lacks the features that are common in alcoholic chronic pancreatitis: calculi, dilated and tortuous ducts, pseudocyst formation and areas of fat necrosis. Histologically, alcoholic chronic pancreatitis lacks the dense periductal lymphoplasmacytic infiltration, the obliterative venulitis, the often diffuse fibrosis, the granulocytic epithelial lesions and the common inflammatory involvement of the bile duct. Autoimmune pancreatitis must also be distinguished from paraduodenal pancreatitis. The latter disease generally develops in the region of the pancreas between the intrapancreatic bile duct and the duodenum proximal to the ampulla of Vater and in the region of the minor papilla. In these areas, and in particular in the duodenal wall, there is inflammation and fibrosis, often associated with cystic structures. All these features are lacking in autoimmune pancreatitis.
Other types of chronic pancreatitis
Metabolic Chronic Pancreatitis
Chronic pancreatitis may be associated with hypercalcemic syndromes such as those that may occur in primary hyperparathyroidism. 118 The morphological changes are similar to those seen in alcoholic chronic pancreatitis. Fibrotic changes in the pancreatic have also been observed in patients who underwent chronic dialysis because of renal insufficiency.
Tropical Chronic Pancreatitis
This disease has also been referred to as tropical calculous pancreatitis and, if diabetes is the prevailing symptom, as fibrocalculous pancreatic diabetes. Tropical chronic pancreatitis is limited to countries in central Africa, Brazil and southern Asia, especially India, which lie close to the equator. This disease is associated with malnutrition in childhood and usually occurs in adolescents. Recently, it was found that SPINK1 mutations are associated with tropical pancreatitis and therefore seem to be involved in its etiopathogenesis. 119 Morphologically, tropical pancreatitis has been compared with alcoholic chronic pancreatitis. In its late stages it shows intense inter-and partly also intralobular fibrosis and contains numerous small and larger calculi. 120 Nothing is known so far about the early stages of the disease.
Idiopathic Chronic Pancreatitis
Morphologically, there are no systematic studies on this type of pancreatitis; however, calcifications seem to be less frequent than in alcoholic chronic pancreatitis. 121 Idiopathic pancreatitis has two age peaks, one in young patients and the other in elderly patients. 122 It used to be rather common and accounted for 10-25% of all cases of chronic pancreatitis. It can be anticipated, however, that its frequency will drop, once our understanding of the etiology of chronic pancreatitis increases. It is likely that among the patients with idiopathic pancreatitis there may be some with autoimmune pancreatitis.
Chronic pancreatitis associated with anatomic abnormalities
Paraduodenal Pancreatitis
This type of pancreatitis has been described under various names in the literature, which represent the different facets of this inflammation of the pancreas: cystic dystrophy of heterotopic pancreas, 123 periampullary duodenal wall cyst, 124 groove pancreatitis, 12 pancreatic hamartoma of the duodenal wall 125 and paraduodenal pancreatitis. 126 Here, we follow the proposal of Adsay and Zamboni and use the term paraduodenal pancreatitis.
Clinically, this particular pancreatic inflammation is found predominantly in male patients (40-50 years) with a history of alcohol abuse. The main symptoms are severe upper abdominal pain, postprandial vomiting and nausea due to stenosis of the duodenum and weight loss. Jaundice develops in approximately 20% of the patients. Imaging may reveal cystic changes in the duodenal wall, calcifications in the paraduodenal pancreatic tissue, pseudocysts at the duodenal wall, a tumor in the region between the duodenum and the pancreas and irregularities in the pancreatic ducts in the head of the pancreas.
Grossly, there is either thickening and scarring of the duodenal wall, particularly in the area corresponding to the minor papilla, that extend to the adjacent pancreatic head tissue ( Figure 20 ) and/or sieve-like cystic changes in the duodenal wall ( Figure 21 ). The cysts contain clear fluid, but others may have more granular white material and even stones. Occasionally, some of the cysts may have a diameter of several centimeters. The fibrotic tissue that develops in the wall of the pancreas and also involves the groove between the wall and the pancreatic tissue may compress and indent the common bile duct. Microscopically, the chronic inflammatory process resides in the duodenal submucosa, the duodenal wall and the adjacent pancreatic tissue (Table 2) . Typically, there are several small foci of necrosis surrounded by a dense proliferation of myoid cells, which show all the features of myofibroblasts and are positive for muscle markers (Figure 22a ). This change is most prominent in the area corresponding to the submucosa of the minor papilla. Between the myoid proliferations, there may be cystic ductal elements, acinar lobules and some islets as well as nerves. Apart from cystically dilated ducts, there are often pseudocystic lesions filled with acidophilic material and lined by granulation tissue with foreign body giant cell reaction (Figure 22b) . Occasionally, there are also clusters of eosinophils. A common finding associated with the inflammatory changes is Brunner's gland hyperplasia, which contributes to the thickening of the duodenal mucosa. If the inflammatory process in the duodenal wall extends to the adjacent pancreas, the cellular and fibrotic reaction becomes less intense so that the central parts of the pancreatic head are usually not involved.
Pathogenetically, alcohol abuse appears to be a precipitating factor, since most of the patients with paraduodenal pancreatitis are alcoholics. The location of the inflammatory process suggests that there may be some anatomic variation in the region of the minor papilla that makes this appear particularly susceptible to injury by alcohol. It is therefore conceivable that the outflow is obstructed at the level of the minor papilla, as may be seen in some cases of pancreas divisum, a condition in which a fetal-type ductal drainage system persists in the adult pancreas. The fact that the duodenal wall often contains the so-called heterotopic pancreatic tissue may reflect the incomplete involution of the dorsal pancreas in this region and contribute to an obstruction of outflow in this area.
Obstructive Chronic Pancreatitis
In obstructive chronic pancreatitis, there is a focal obstruction of the main pancreatic duct or one of the secondary ducts that lie in the interlobular spaces, leading to ductal dilatation upstream of the stenosis and to atrophy of the acinar cells and replacement by fibrous tissue and islet aggregations. There are various possible causes for a duct obstruction, but the most important and common cause is ductal adenocarcinoma in the head of the pancreas occluding the main pancreatic duct (Figure 23 ). This process leads to a generalized involvement of the gland with interlobular fibrosis, which in longstanding cases is increasingly accompanied by intralobular fibrosis (Table 2 ). Other causes include intraductal papillary-mucinous neoplasms, some cystic and endocrine neoplasms, acquired fibrous strictures of the pancreatic ducts, ductal papillary hyperplasia narrowing the duct lumen and finally viscous mucin blocking the duct lumen.
The effects of all the listed duct obstructing mechanisms can be compared with those of duct ligation in the pancreas. 127, 128 In the early phase after duct ligation, the acini are transformed into small ductal (tubular) complexes. In the next step, the acinar cells disappear, probably due to apoptosis. These changes are associated with an inflammatory and fibrotic reaction involving numerous macrophages. The macrophages are the potential source of cytokines, which stimulate fibrogenesis by fibroblasts that acquire the properties of myofibroblasts. 15 Because the inflammatory reaction takes place in all of the interlobular and intralobular areas of the pancreatic tissue that were once drained by the occluded duct, fibrosis develops in these regions at the same pace, producing interlobular and intralobular fibrosis in equal distribution ( Figure 24 ).
Pancreatic Fibrosis not Associated with Symptoms of Chronic Pancreatitis
A special situation of duct fibrosis is encountered in cystic fibrosis of the pancreas and in pancreatic lobular fibrosis, which is frequently observed in elderly persons. Whereas the first condition causes duct obstruction due to clogging with viscous mucin, the second condition leads to narrowing of the duct lumen by papillary hyperplasia of the duct epithelium. In cystic fibrosis, complete or almost complete (inter-and intralobular) fibrosis develops slowly after birth, 129 which, after many years, is replaced by fatty tissue, 130 a process that is not understood so far, but is of great interest for the resolution of fibrosis. In cystic fibrosis that is not caused by the common D F508 mutation but results from other mutations such as R117H mutation, acute pancreatitis may develop. 131 In elderly persons, the pancreas may contain ducts narrowed by ductal papillary hyperplasia, a lesion that has now been termed pancreatic intraepithelial neoplasia type 1B. 132 In association with this lesion, there may be patchy lobular fibrosis in the periphery of the pancreas (Figure 25 ). The fibrosis affects the lobes that are drained by ducts showing PanIN-1B lesions. The extent of this lobular fibrosis varies from person to person; the most severe form and the highest incidence (up to 50%) are found in persons older than 60 years. 133 
Pseudotumors and other tumor-like lesions
Pseudotumors and other tumor-like lesions are nonneoplastic changes that may mimic pancreatic cancer, in particular ductal adenocarcinoma. Pseudotumors give rise to detectable solid masses and may be either of inflammatory or noninflammatory origin (for further reading see Adsay et al 134 ).
The most important and common inflammatory pseudotumors are those arising in association with autoimmune (lymphoplasmacytic sclerosing) pancreatitis. 99 These tumors have to be distinguished from malignant fibrous histiocytoma and true inflammatory myofibroblastic tumor. Inflammatory pseudotumors may occasionally be seen in paraduodenal pancreatitis and other rare inflammations such as mycobacterial infection. Among the noninflammatory pseudotumors are ampullary adenomyoma, splenic heterotopia, lipomatous pseudohypertrophy and hamartoma. 135, 136 The tumor-like lesions mainly include cystic changes (see article on cystic neoplasia) and duct changes (see article on ductal adenocarcinoma). 
